Trinity Biotech Plans Reverse ADS Split to Meet Nasdaq Requirements

AI-generated NewsSnap summary based on source reporting.
Published: 2026-07-22
Category: business
Source: Markets Insider (via GLOBE NEWSWIRE)
Original source

Trinity Biotech plc intends to alter its American depositary share (ADS) ratio, effectively implementing a 1-for-30 reverse ADS split. This strategic move aims to increase the company's share price to comply with Nasdaq's minimum bid price rule. The change is also expected to broaden the company's appeal to a wider range of investors.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai